There was an increase in use of neuraxial anesthesia and peripheral nerve block analgesia rather than general anesthesia for hip fracture procedures.

The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.

Ustekinumab is associated with a higher rate of clinical remission at 6 months compared with anti-TNF therapy among patients with CLDP. Ustekinumab may be more effective than anti-tumor necrosis ...

From 2016 to 2022, 5.3% of all US emergency department visits were related to low back pain, with opioid administration and prescription decreasing during this same time period.

There was an overall decrease in influenza vaccine uptake among US adults from 2020 to 2024, according to a study published online.

Older adults with insomnia are more vulnerable to depressive mood and symptoms in response to inflammatory exposure.

The Trump administration’s immigration policies are having negative effects on health care, impacting patients and health ...

Achieving remission is increasingly possible among patients with gout receiving ULT, with rates increasing over time.

A broad spectrum of systemic inflammatory manifestations defines VEXAS syndrome, with cutaneous, respiratory, and vascular involvement commonly reported.

Associations between neighborhood characteristics (e.g. air pollution and neighborhood socioeconomic status) and mental health outcomes varied by age.

Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.

The US Food and Drug Administration has announced a plan to revoke 52 food standards after concluding they are "obsolete and unnecessary." ...